Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew H Spitzer

Showing results (71-80 of 82) with videos related to

Pageof 9
Sort By:
Cell|March 17, 2023
Dynamic CD8<sup>+</sup> T cell responses to cancer immunotherapy in human regional lymph nodes are disrupted in metastatic lymph nodesMaha K Rahim, Trine Line H Okholm, Kyle B Jones, et al.
Biorxiv : the Preprint Server for Biology|March 31, 2025
IL-6 underlies microenvironment immunosuppression and resistance to therapy in glioblastomaJacob S Young, Nam Woo Cho, Calixto-Hope G Lucas, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2026
Immune activation during broadly neutralizing antibody-mediated HIV suppression prior to post-intervention controlJulia A Wagner, Demi A Sandel, Ravi K Patel, et al.
Cancer Research|April 13, 2026
IL-6 underlies microenvironment immunosuppression and resistance to therapy in glioblastomaJacob S Young, Nam Woo Cho, Calixto-Hope G Lucas, et al.
Cell|May 7, 2022
Lymph node colonization induces tumor-immune tolerance to promote distant metastasisNathan E Reticker-Flynn, Weiruo Zhang, Julia A Belk, et al.
Immunity|January 30, 2026
Commensal-myeloid crosstalk in neonatal skin regulates interleukin-1 signaling and cutaneous type 17 inflammationMiqdad O Dhariwala, Ricardo O Carale, Andrea M DeRogatis, et al.
Nature Communications|January 12, 2024
Epigenetic reprogramming shapes the cellular landscape of schwannomaS John Liu, Tim Casey-Clyde, Nam Woo Cho, et al.
Biorxiv : the Preprint Server for Biology|May 18, 2026
Scalable longitudinal imaging and transcriptomics of cells in dynamic enclosuresTarun K Khurana, Liz Y Wu, Pier Federico Gherardini, et al.
Biorxiv : the Preprint Server for Biology|February 26, 2024
Disrupting CD38-driven T cell dysfunction restores sensitivity to cancer immunotherapyOr-Yam Revach, Angelina M Cicerchia, Ofir Shorer, et al.
Cell Reports. Medicine|June 27, 2025
Overcoming resistance to immunotherapy by targeting CD38 in human tumor explantsOr-Yam Revach, Angelina M Cicerchia, Ofir Shorer, et al.
Pageof 9

Showing results (71-80 of 82) with videos related to

Sort By:
Pageof 9
Cell|March 17, 2023
Dynamic CD8<sup>+</sup> T cell responses to cancer immunotherapy in human regional lymph nodes are disrupted in metastatic lymph nodesMaha K Rahim, Trine Line H Okholm, Kyle B Jones, et al.
Biorxiv : the Preprint Server for Biology|March 31, 2025
IL-6 underlies microenvironment immunosuppression and resistance to therapy in glioblastomaJacob S Young, Nam Woo Cho, Calixto-Hope G Lucas, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2026
Immune activation during broadly neutralizing antibody-mediated HIV suppression prior to post-intervention controlJulia A Wagner, Demi A Sandel, Ravi K Patel, et al.
Cancer Research|April 13, 2026
IL-6 underlies microenvironment immunosuppression and resistance to therapy in glioblastomaJacob S Young, Nam Woo Cho, Calixto-Hope G Lucas, et al.
Cell|May 7, 2022
Lymph node colonization induces tumor-immune tolerance to promote distant metastasisNathan E Reticker-Flynn, Weiruo Zhang, Julia A Belk, et al.
Immunity|January 30, 2026
Commensal-myeloid crosstalk in neonatal skin regulates interleukin-1 signaling and cutaneous type 17 inflammationMiqdad O Dhariwala, Ricardo O Carale, Andrea M DeRogatis, et al.
Nature Communications|January 12, 2024
Epigenetic reprogramming shapes the cellular landscape of schwannomaS John Liu, Tim Casey-Clyde, Nam Woo Cho, et al.
Biorxiv : the Preprint Server for Biology|May 18, 2026
Scalable longitudinal imaging and transcriptomics of cells in dynamic enclosuresTarun K Khurana, Liz Y Wu, Pier Federico Gherardini, et al.
Biorxiv : the Preprint Server for Biology|February 26, 2024
Disrupting CD38-driven T cell dysfunction restores sensitivity to cancer immunotherapyOr-Yam Revach, Angelina M Cicerchia, Ofir Shorer, et al.
Cell Reports. Medicine|June 27, 2025
Overcoming resistance to immunotherapy by targeting CD38 in human tumor explantsOr-Yam Revach, Angelina M Cicerchia, Ofir Shorer, et al.
Pageof 9